Search

Your search keyword '"Patel, Shashank"' showing total 141 results

Search Constraints

Start Over You searched for: Author "Patel, Shashank" Remove constraint Author: "Patel, Shashank"
141 results on '"Patel, Shashank"'

Search Results

5. LAIR-1 agonism as a therapy for acute myeloid leukemia

6. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

8. An interactive web application utilizing machine learning techniques to identify and flag fabricated news articles.

10. The FLRT3-UNC5B checkpoint pathway inhibits T cell–based cancer immunotherapies

13. A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.

17. Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy

20. The transcription factor BACH2 promotes tumor immunosuppression

22. BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers

24. Cancer genes disfavoring T cell immunity identified via integrated systems approach

27. List of contributors

28. A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells

31. Identification of essential genes for cancer immunotherapy

32. 333 Targeting the apical intracellular checkpoint CISH unleashes T cell neoantigen reactivity and effector program

33. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

34. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

35. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

37. Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy

38. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

40. T cell stemness and dysfunction in tumors are triggered by a common mechanism

41. Identification of essential genes for cancer immunotherapy

43. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

45. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

47. Abstract 4034: Immunotherapy generates selective pressure to create an escape tumor with increased susceptibility to treatment with T cell based therapies

48. Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors

50. Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance

Catalog

Books, media, physical & digital resources